Cancer Family
Head and Neck Neoplasm
CI-CAN-00000021Explore in graph →
Non-malignant1,572 active trials17 approved drugs142 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000021Explore in graph →
Clinical trials
6,373 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00377247 | Active Immunization of Patients With Carcinoma of Oral Cavity or Oropharynx With Autologous Dendritic Cells Transfected With DNA From Autologous Tumor | terminated | Phase 1 | 5 | University of PittsburghOTHER | 1 | Jul 11, 2016 | clinicaltrials |
| NCT02080416 | Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors | terminated | Early Phase 1 | 1 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jun 10, 2016 |
| clinicaltrials |
| NCT00537199 | OraTest in Combination With Visual Examination and Visual Examination Alone | terminated | Phase 3 | 1 | M.D. Anderson Cancer CenterOTHER | 1 | May 13, 2016 | clinicaltrials |
| NCT00872404 | A Study of CP-751,871 in Patients With Recurrent Squamous Head and Neck Carcinoma | terminated | Phase 2 | 37 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | Apr 20, 2016 | clinicaltrials |
| NCT00623129 | Electroacupuncture in Treating Chronic Dry Mouth Caused By Radiation Therapy in Patients With Head and Neck Cancer | terminated | N/A | 30 | Mayo ClinicOTHER | 1 | Apr 19, 2016 | clinicaltrials |
| NCT00891904 | Radiation Therapy and Cetuximab in Treating Patients With Recurrent Head and Neck Cancer | terminated | N/A | 2 | Roswell Park Cancer InstituteOTHER | 1 | Apr 14, 2016 | clinicaltrials |
| NCT02479178 | A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck(iNSITE2) | terminated | Phase 2 | 73 | BIND TherapeuticsINDUSTRY | 2 | Apr 14, 2016 | clinicaltrials |
| NCT01285635 | A Study of AT-101 in Combination With Docetaxel in Squamous Cell Carcinoma Of The Head and Neck | terminated | Phase 2 | 35 | University of Michigan Rogel Cancer CenterOTHER | 1 | Mar 31, 2016 | clinicaltrials |
| NCT00994201 | Magnetic Resonance Imaging (MRI) in the Assessment of Head and Neck Squamous Cell Carcinoma (HNSCC) Response | terminated | — | 10 | OHSU Knight Cancer InstituteOTHER | 1 | Mar 25, 2016 | clinicaltrials |
| NCT00670397 | Photodynamic Therapy Using HPPH in Treating Patients With Recurrent Dysplasia, Carcinoma in Situ, or Stage I Oral Cavity Cancer | terminated | Phase 1 | 11 | Roswell Park Cancer InstituteOTHER | 1 | Mar 16, 2016 | clinicaltrials |
| NCT01161498 | Study of Safety and Efficacy of Talimogene Laherparepvec With Cisplatin and Radiotherapy for Treatment of Locally Advanced Head and Neck Cancer | terminated | Phase 3 | 5 | BioVex LimitedINDUSTRY | 2 | Feb 8, 2016 | clinicaltrials |
| NCT00272181 | Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer | terminated | Phase 2 | 15 | Sesen Bio, Inc.INDUSTRY | 2 | Dec 23, 2015 | clinicaltrials |
| NCT00412776 | Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancer | terminated | Phase 2 / Phase 3 | 165 | Sesen Bio, Inc.INDUSTRY | 18 | Dec 23, 2015 | clinicaltrials |
| NCT00599131 | Cetuximab and Radiation Therapy in Laryngeal Cancer Patients Who Have Responded to One Cycle of Chemotherapy (SPORE) | terminated | Phase 2 | 4 | University of Michigan Rogel Cancer CenterOTHER | 1 | Dec 3, 2015 | clinicaltrials |
| NCT00006994 | S9908: Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat | terminated | Phase 3 | 23 | SWOG Cancer Research NetworkNETWORK | 2 | Nov 18, 2015 | clinicaltrials |
| NCT00720083 | Chemotherapy and Radiation Therapy (RT) With or Without Vandetanib in Treating Patients With High-Risk Stage III or Stage IV Head and Neck Cancer | terminated | Phase 2 | 34 | Radiation Therapy Oncology GroupNETWORK | 1 | Nov 17, 2015 | clinicaltrials |
| NCT02042885 | A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced Cancer | terminated | Phase 1 / Phase 2 | 79 | Otsuka Novel Products GmbHINDUSTRY | 1 | Oct 20, 2015 | clinicaltrials |
| NCT00798057 | Proton Radiation Therapy for Pituitary Adenoma(PI01) | terminated | — | 16 | University of FloridaOTHER | 1 | Oct 5, 2015 | clinicaltrials |
| NCT00002735 | SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of the Hypopharynx or Tongue | terminated | Phase 2 | 68 | SWOG Cancer Research NetworkNETWORK | 1 | Sep 30, 2015 | clinicaltrials |
| NCT01949740 | Patient Preferences in Making Treatment Decisions in Patients With Stage I-IVA Oropharyngeal Cancer | terminated | — | 37 | University of ChicagoOTHER | 1 | Sep 2, 2015 | clinicaltrials |
| NCT01111942 | A Pilot Study of Induction Chemotherapy Followed by Surgery for Locally Advanced Resectable Head and Neck Cancer | terminated | Early Phase 1 | 4 | Southern Illinois UniversityOTHER | 1 | Aug 5, 2015 | clinicaltrials |
| NCT00506324 | Oropharyngeal Function After Radiotherapy With IMRT | terminated | — | 125 | Northwestern UniversityOTHER | 1 | Jul 14, 2015 | clinicaltrials |
| NCT02058017 | OPB-51602 in Locally Advanced Nasopharyngeal Carcinoma Prior to Definitive Chemoradiotherapy | terminated | Phase 1 | 9 | National University Hospital, SingaporeOTHER | 1 | Jun 19, 2015 | clinicaltrials |
| NCT01694576 | NPC Staged N2-3M0:Adjuvant Chemotherapy or Just Observation After Concurrent Chemoradiation | terminated | Phase 2 | 10 | Jiangsu Cancer Institute & HospitalOTHER | 1 | Jun 15, 2015 | clinicaltrials |
| NCT00176241 | Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Metastatic or Recurrent Head & Neck Cancer | terminated | Phase 1 | 7 | Susanne ArnoldOTHER | 1 | Jun 8, 2015 | clinicaltrials |
| NCT01701466 | Neoviderm Skin Emulsion in the Prevention of Radiation Dermatitis | terminated | Phase 2 | 14 | Sir Mortimer B. Davis - Jewish General HospitalOTHER | 1 | May 25, 2015 | clinicaltrials |
| NCT00159978 | Validation of 18F-MISO-PET and 18F-FLT-PET | terminated | — | 21 | Radboud University Medical CenterOTHER | 1 | May 7, 2015 | clinicaltrials |
| NCT00088907 | Phase III Trial Of Docetaxel Versus Docetaxel Plus ZD1839 In Head And Neck Cancer | terminated | Phase 3 | 270 | National Cancer Institute (NCI)NIH | 1 | May 6, 2015 | clinicaltrials |
| NCT00073450 | Study of Lonafarnib in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck (Study P02530) | terminated | Phase 2 | 15 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Apr 21, 2015 | clinicaltrials |
| NCT00200408 | Assessment of Early Genetic Changes in Smokers | terminated | — | 10 | Montefiore Medical CenterOTHER | 1 | Apr 8, 2015 | clinicaltrials |
| NCT01548846 | Impact of Tomotherapy on Xerostomia and Quality of Life of Patients With Cancer of the Upper Aero-digestive Tract(TOQUAL) | terminated | Phase 2 | 11 | Centre Francois BaclesseOTHER | 1 | Mar 13, 2015 | clinicaltrials |
| NCT02105337 | Tegaderm and Visual Evoked Potentials | terminated | — | 6 | Rutgers, The State University of New JerseyOTHER | 1 | Mar 11, 2015 | clinicaltrials |
| NCT00934739 | A Study of High-Risk Oral Cavity Cancer | terminated | Phase 2 / Phase 3 | 150 | National Health Research Institutes, TaiwanOTHER | 0 | Feb 25, 2015 | clinicaltrials |
| NCT01219673 | Symptom Burden in Head and Neck Cancer | terminated | Phase 1 / Phase 2 | 1 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 10, 2015 | clinicaltrials |
| NCT00525135 | Valproic Acid (Depakote ER) in Patients With Advanced Thyroid Cancer | terminated | Phase 2 | 5 | University of California, San FranciscoOTHER | 1 | Feb 3, 2015 | clinicaltrials |
| NCT01333852 | Metformin Plus Paclitaxel for Metastatic or Recurrent Head and Neck Cancer(METTAX) | terminated | Phase 2 | 45 | Lucas Vieira dos SantosOTHER | 1 | Jan 27, 2015 | clinicaltrials |
| NCT00354523 | Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma | terminated | Phase 1 / Phase 2 | 21 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 17, 2014 | clinicaltrials |
| NCT01587820 | Intra-arterial Versus Intravenous Cisplatin, Combined With Radiation, for Oral Cavity and Oropharynx Cancer | terminated | Early Phase 1 | 1 | Southern Illinois UniversityOTHER | 1 | Dec 5, 2014 | clinicaltrials |
| NCT01254734 | Transoral Robotic Surgery in Treating Patients With Benign or Stage I-IV Head and Neck Cancer | terminated | N/A | 7 | City of Hope Medical CenterOTHER | 1 | Nov 10, 2014 | clinicaltrials |
| NCT01088763 | Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia | terminated | Phase 1 | 129 | National Cancer Institute (NCI)NIH | 2 | Nov 5, 2014 | clinicaltrials |
| NCT01549379 | Dynamic Contrast Enhanced Computed Tomography (CT) for Head and Neck Cancer | terminated | N/A | 1 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Oct 15, 2014 | clinicaltrials |
| NCT01790516 | Use of Pharmacogenetics to Select Erbitux or Cisplatin to Treat Head and Neck Cancer | terminated | N/A | 2 | Georgetown UniversityOTHER | 1 | Oct 2, 2014 | clinicaltrials |
| NCT01305772 | Identification of Gene Expression Signature for Panitumumab Sensitivity in Untreated Locally Advanced SCCHN(TOP0901) | terminated | Phase 2 | 6 | Neal ReadyOTHER | 1 | Aug 29, 2014 | clinicaltrials |
| NCT01682031 | Selenomethionine in Reducing Mucositis in Patients With Locally Advanced Head and Neck Cancer Who Are Receiving Cisplatin and Radiation Therapy | terminated | Phase 2 | 18 | Roswell Park Cancer InstituteOTHER | 2 | Aug 22, 2014 | clinicaltrials |
| NCT01403259 | SOX as Salvage Treatment in Nasopharyngeal Carcinoma | terminated | Phase 2 | 16 | Fudan UniversityOTHER | 1 | Aug 20, 2014 | clinicaltrials |
| NCT00911326 | Evaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell Carcinoma | terminated | Phase 3 | 101 | Navidea BiopharmaceuticalsINDUSTRY | 1 | Aug 8, 2014 | clinicaltrials |
| NCT02209701 | Pharmacokinetic Study of Porfiromycin in Head and Neck Cancer and Other Cancer Patients With Solid Tumors | terminated | Phase 1 | 3 | Boehringer IngelheimINDUSTRY | 0 | Aug 6, 2014 | clinicaltrials |
| NCT02183246 | Porfiromycin Used as an Adjuvant to Radiation Therapy in Postoperative Head and Neck Cancer Patients | terminated | Phase 3 | 3 | Boehringer IngelheimINDUSTRY | 0 | Jul 8, 2014 | clinicaltrials |
| NCT00530088 | Photodynamic Therapy Using Porfimer Sodium in Treating Patients With Recurrent Mouth or Throat Dysplasia or Recurrent In Situ Cancer or Stage I Cancer of the Mouth or Throat | terminated | N/A | 30 | Roswell Park Cancer InstituteOTHER | 1 | Jul 4, 2014 | clinicaltrials |
| NCT00002947 | Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer | terminated | Phase 1 | 35 | Yale UniversityOTHER | 1 | Jul 2, 2014 | clinicaltrials |
Data updated 23 days agoSource updated Jul 11, 2016source: clinicaltrials